The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.
The global Insulin Delivery Devices market size is expected to reach US$ 14100 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Insulin Delivery Devices in various end use industries. The expanding demands from the Patients/Homecare and Hospitals & Clinics, are propelling Insulin Delivery Devices market. Insulin Pens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Insulin Pumps segment is estimated at % CAGR for the next seven-year period.
In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Insulin Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Insulin Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Insulin Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Insulin Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Insulin Delivery Devices covered in this report include Novo Nordisk, Sanofi, BD, Eli Lilly, Medtronic, Animas, Beta Bionics, Cellnovo and Copernicus, etc.
The global Insulin Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Novo Nordisk
- Sanofi
- BD
- Eli Lilly
- Medtronic
- Animas
- Beta Bionics
- Cellnovo
- Copernicus
- Dance Biopharm
- Debiotech
- Insulet
- MannKind
- Owen Mumford
- Roche
- SOOIL
- Tandem Diabetes Care
- Valeritas
- West Pharma
- Ypsomed
Global Insulin Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Insulin Delivery Devices market, Segment by Type:
Insulin Pens
Insulin Pumps
Insulin Syringes
Others
Global Insulin Delivery Devices market, by Application
Patients/Homecare
Hospitals & Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Insulin Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Insulin Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Insulin Delivery Devices Market Overview
1.1 Insulin Delivery Devices Product Overview
1.2 Insulin Delivery Devices Market Segment by Type
1.2.1 Insulin Pens
1.2.2 Insulin Pumps
1.2.3 Insulin Syringes
1.2.4 Others
1.3 Global Insulin Delivery Devices Market Size by Type
1.3.1 Global Insulin Delivery Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Insulin Delivery Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Insulin Delivery Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Insulin Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Insulin Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Insulin Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Insulin Delivery Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Insulin Delivery Devices Sales Breakdown by Type (2018-2023)
2 Global Insulin Delivery Devices Market Competition by Company
2.1 Global Top Players by Insulin Delivery Devices Sales (2018-2023)
2.2 Global Top Players by Insulin Delivery Devices Revenue (2018-2023)
2.3 Global Top Players by Insulin Delivery Devices Price (2018-2023)
2.4 Global Top Manufacturers Insulin Delivery Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Insulin Delivery Devices Market Competitive Situation and Trends
2.5.1 Insulin Delivery Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Insulin Delivery Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Insulin Delivery Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Insulin Delivery Devices Market
2.8 Key Manufacturers Insulin Delivery Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Insulin Delivery Devices Status and Outlook by Region
3.1 Global Insulin Delivery Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Insulin Delivery Devices Historic Market Size by Region
3.2.1 Global Insulin Delivery Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Insulin Delivery Devices Sales in Value by Region (2018-2023)
3.2.3 Global Insulin Delivery Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Insulin Delivery Devices Forecasted Market Size by Region
3.3.1 Global Insulin Delivery Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Insulin Delivery Devices Sales in Value by Region (2024-2029)
3.3.3 Global Insulin Delivery Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Insulin Delivery Devices by Application
4.1 Insulin Delivery Devices Market Segment by Application
4.1.1 Patients/Homecare
4.1.2 Hospitals & Clinics
4.2 Global Insulin Delivery Devices Market Size by Application
4.2.1 Global Insulin Delivery Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Insulin Delivery Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Insulin Delivery Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Insulin Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Insulin Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Insulin Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Insulin Delivery Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Insulin Delivery Devices Sales Breakdown by Application (2018-2023)
5 North America Insulin Delivery Devices by Country
5.1 North America Insulin Delivery Devices Historic Market Size by Country
5.1.1 North America Insulin Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Insulin Delivery Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Insulin Delivery Devices Sales in Value by Country (2018-2023)
5.2 North America Insulin Delivery Devices Forecasted Market Size by Country
5.2.1 North America Insulin Delivery Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Insulin Delivery Devices Sales in Value by Country (2024-2029)
6 Europe Insulin Delivery Devices by Country
6.1 Europe Insulin Delivery Devices Historic Market Size by Country
6.1.1 Europe Insulin Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Insulin Delivery Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Insulin Delivery Devices Sales in Value by Country (2018-2023)
6.2 Europe Insulin Delivery Devices Forecasted Market Size by Country
6.2.1 Europe Insulin Delivery Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Insulin Delivery Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Insulin Delivery Devices by Region
7.1 Asia-Pacific Insulin Delivery Devices Historic Market Size by Region
7.1.1 Asia-Pacific Insulin Delivery Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Insulin Delivery Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Insulin Delivery Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Insulin Delivery Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Insulin Delivery Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Insulin Delivery Devices Sales in Value by Region (2024-2029)
8 Latin America Insulin Delivery Devices by Country
8.1 Latin America Insulin Delivery Devices Historic Market Size by Country
8.1.1 Latin America Insulin Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Insulin Delivery Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Insulin Delivery Devices Sales in Value by Country (2018-2023)
8.2 Latin America Insulin Delivery Devices Forecasted Market Size by Country
8.2.1 Latin America Insulin Delivery Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Insulin Delivery Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Insulin Delivery Devices by Country
9.1 Middle East and Africa Insulin Delivery Devices Historic Market Size by Country
9.1.1 Middle East and Africa Insulin Delivery Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Insulin Delivery Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Insulin Delivery Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Insulin Delivery Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Insulin Delivery Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Insulin Delivery Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Insulin Delivery Devices Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Sanofi Insulin Delivery Devices Products Offered
10.2.5 Sanofi Recent Development
10.3 BD
10.3.1 BD Company Information
10.3.2 BD Introduction and Business Overview
10.3.3 BD Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 BD Insulin Delivery Devices Products Offered
10.3.5 BD Recent Development
10.4 Eli Lilly
10.4.1 Eli Lilly Company Information
10.4.2 Eli Lilly Introduction and Business Overview
10.4.3 Eli Lilly Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Eli Lilly Insulin Delivery Devices Products Offered
10.4.5 Eli Lilly Recent Development
10.5 Medtronic
10.5.1 Medtronic Company Information
10.5.2 Medtronic Introduction and Business Overview
10.5.3 Medtronic Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Medtronic Insulin Delivery Devices Products Offered
10.5.5 Medtronic Recent Development
10.6 Animas
10.6.1 Animas Company Information
10.6.2 Animas Introduction and Business Overview
10.6.3 Animas Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Animas Insulin Delivery Devices Products Offered
10.6.5 Animas Recent Development
10.7 Beta Bionics
10.7.1 Beta Bionics Company Information
10.7.2 Beta Bionics Introduction and Business Overview
10.7.3 Beta Bionics Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Beta Bionics Insulin Delivery Devices Products Offered
10.7.5 Beta Bionics Recent Development
10.8 Cellnovo
10.8.1 Cellnovo Company Information
10.8.2 Cellnovo Introduction and Business Overview
10.8.3 Cellnovo Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cellnovo Insulin Delivery Devices Products Offered
10.8.5 Cellnovo Recent Development
10.9 Copernicus
10.9.1 Copernicus Company Information
10.9.2 Copernicus Introduction and Business Overview
10.9.3 Copernicus Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Copernicus Insulin Delivery Devices Products Offered
10.9.5 Copernicus Recent Development
10.10 Dance Biopharm
10.10.1 Dance Biopharm Company Information
10.10.2 Dance Biopharm Introduction and Business Overview
10.10.3 Dance Biopharm Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Dance Biopharm Insulin Delivery Devices Products Offered
10.10.5 Dance Biopharm Recent Development
10.11 Debiotech
10.11.1 Debiotech Company Information
10.11.2 Debiotech Introduction and Business Overview
10.11.3 Debiotech Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Debiotech Insulin Delivery Devices Products Offered
10.11.5 Debiotech Recent Development
10.12 Insulet
10.12.1 Insulet Company Information
10.12.2 Insulet Introduction and Business Overview
10.12.3 Insulet Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Insulet Insulin Delivery Devices Products Offered
10.12.5 Insulet Recent Development
10.13 MannKind
10.13.1 MannKind Company Information
10.13.2 MannKind Introduction and Business Overview
10.13.3 MannKind Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.13.4 MannKind Insulin Delivery Devices Products Offered
10.13.5 MannKind Recent Development
10.14 Owen Mumford
10.14.1 Owen Mumford Company Information
10.14.2 Owen Mumford Introduction and Business Overview
10.14.3 Owen Mumford Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Owen Mumford Insulin Delivery Devices Products Offered
10.14.5 Owen Mumford Recent Development
10.15 Roche
10.15.1 Roche Company Information
10.15.2 Roche Introduction and Business Overview
10.15.3 Roche Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Roche Insulin Delivery Devices Products Offered
10.15.5 Roche Recent Development
10.16 SOOIL
10.16.1 SOOIL Company Information
10.16.2 SOOIL Introduction and Business Overview
10.16.3 SOOIL Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.16.4 SOOIL Insulin Delivery Devices Products Offered
10.16.5 SOOIL Recent Development
10.17 Tandem Diabetes Care
10.17.1 Tandem Diabetes Care Company Information
10.17.2 Tandem Diabetes Care Introduction and Business Overview
10.17.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Tandem Diabetes Care Insulin Delivery Devices Products Offered
10.17.5 Tandem Diabetes Care Recent Development
10.18 Valeritas
10.18.1 Valeritas Company Information
10.18.2 Valeritas Introduction and Business Overview
10.18.3 Valeritas Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Valeritas Insulin Delivery Devices Products Offered
10.18.5 Valeritas Recent Development
10.19 West Pharma
10.19.1 West Pharma Company Information
10.19.2 West Pharma Introduction and Business Overview
10.19.3 West Pharma Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.19.4 West Pharma Insulin Delivery Devices Products Offered
10.19.5 West Pharma Recent Development
10.20 Ypsomed
10.20.1 Ypsomed Company Information
10.20.2 Ypsomed Introduction and Business Overview
10.20.3 Ypsomed Insulin Delivery Devices Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Ypsomed Insulin Delivery Devices Products Offered
10.20.5 Ypsomed Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Insulin Delivery Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Insulin Delivery Devices Industrial Chain Analysis
11.4 Insulin Delivery Devices Market Dynamics
11.4.1 Insulin Delivery Devices Industry Trends
11.4.2 Insulin Delivery Devices Market Drivers
11.4.3 Insulin Delivery Devices Market Challenges
11.4.4 Insulin Delivery Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Insulin Delivery Devices Distributors
12.3 Insulin Delivery Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
